APA (7th ed.) Citation

Atas Ipek, S., Yaslikaya, S., Kara, I. O., Koseci, T., Bayram, E., Asarkaya, E., . . . Yurdatap Koc, D. (2026). Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study. Journal of Clinical Medicine, 15(13), 4880. https://doi.org/10.3390/jcm15134880

Chicago Style (17th ed.) Citation

Atas Ipek, Suheda, et al. "Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study." Journal of Clinical Medicine 15, no. 13 (2026): 4880. https://doi.org/10.3390/jcm15134880.

MLA (9th ed.) Citation

Atas Ipek, Suheda, et al. "Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study." Journal of Clinical Medicine, vol. 15, no. 13, 2026, p. 4880, https://doi.org/10.3390/jcm15134880.